The White Vein Tablets Recall 2026 was issued after testing revealed excessive active ingredient levels in Alkaloids Chewable Tablets White Vein products distributed nationwide.
Here’s what consumers need to know.
Alkaloids Chewable Tablets White Vein Recall 2026 Safety Alert: What Consumers Need to Know
Shaman Botanicals, LLC has announced a voluntary nationwide recall of:
What Is the Alkaloids Chewable Tablets Recall 2026?
The recall was initiated after testing found that the product contains 7-Hydroxymitragynine (7-OH) at levels exceeding the labeled amount of 7.5 mg per tablet. The White Vein Tablets Recall 2026 affects products sold online and through various retailers across the United States.
Consumers involved in the White Vein Tablets Recall 2026 should stop using the product immediately and follow the manufacturer’s recall instructions.
This means consumers may unknowingly ingest a stronger dose than intended.
The White Vein Tablets Recall 2026 highlights the importance of monitoring supplement ingredients and manufacturing standards. Consumers should remain cautious when purchasing herbal or alkaloid products that may contain higher-than-expected active compounds.
Affected Products
The recall includes:
- 2-Count Bag – UPC: 810057763724
- 20-Count Bag – UPC: 810057763830
- 30-Count Bottle – UPC: 810057763779
- Lot Number: B# AAW.501.3
- All expiration dates under this lot
The product was distributed nationwide, including:
- Online sales
- Wholesale distribution
- Retail outlets
Why Is This Recall Serious?
The concern is not contamination — it is potency.
The product contains higher-than-declared levels of 7-Hydroxymitragynine (7-OH), a compound known for producing opioid-like effects.
Higher potency may increase the risk of:
- Sedation
- Respiratory depression
- Dizziness
- Nausea
- Increased dependence risk
- Other adverse effects
Even when labeled amounts appear small, potency inconsistencies in supplements can create unpredictable health risks.
As of the recall announcement, no adverse events had been reported.
What Is 7-Hydroxymitragynine?
7-Hydroxymitragynine (7-OH) is an alkaloid derived from kratom (Mitragyna speciosa). It is known to interact with opioid receptors in the body.
The FDA has previously warned about the risks associated with products containing concentrated 7-OH, especially when not properly regulated or labeled.
Supplements containing undeclared or excessive active ingredients present particular risks because consumers may not realize they are consuming stronger doses.
What Consumers Should Do Immediately
According to the recall notice, the Alkaloids Chewable Tablets White Vein Recall 2026 affects a single lot distributed nationwide.
If you have purchased Alkaloids Chewable Tablets – White Vein, take the following steps:
1️⃣ Stop Using the Product
Do not consume additional tablets.
2️⃣ Check the Lot Number
Look for Lot B# AAW.501.3 on the packaging.
3️⃣ Return for Refund
Consumers may return affected products for a refund through the company’s recall portal:
https://recall.cbdamericanshaman.com
4️⃣ Monitor for Symptoms
If you experience unusual symptoms such as:
- Extreme drowsiness
- Breathing difficulties
- Confusion
- Unusual heart rate
Contact a healthcare provider immediately.
5️⃣ Report Adverse Reactions
Adverse events can be reported to the FDA MedWatch program.
Anyone who purchased products included in the White Vein Tablets Recall 2026 should stop using the tablets immediately and follow the recall instructions provided by the manufacturer or the FDA.
Why Undeclared Alkaloid Levels Can Be Dangerous
Dietary supplements must accurately label the amount of active ingredients they contain so consumers can make informed decisions about dosage and safety. When a product contains higher-than-declared amounts of an active compound, users may unknowingly consume more than intended. This can increase the risk of side effects such as dizziness, nausea, or other adverse reactions.
In this recall, testing revealed that the chewable tablets contained higher levels of 7-hydroxymitragynine, an alkaloid derived from kratom. Products containing concentrated forms of this compound have raised safety concerns because they may produce opioid-like effects in the body.
Because of these potential risks, regulators encourage consumers to stop using affected products and return them for a refund. The White Vein Tablets Recall 2026 affects products sold through online retailers and supplement distributors across the United States.
Consumers affected by the White Vein Tablets Recall 2026 should stop using the tablets immediately and follow the recall instructions provided by the manufacturer or the FDA.
Company Contact Information
Consumers with questions may contact the company’s Quality Department:
- Phone: 855-427-7386
- Email: Quality@CBDAmericanShaman.com
- Hours: Monday – Friday, 9 AM – 5 PM CST
How to Identify the Product
The recalled product is sold as chewable tablets in:
- Small bags (2-count or 20-count)
- Bottled packaging (30-count)
Check the UPC codes and lot number listed above before use.
If you are unsure, do not consume it.
Why Supplement Recalls Matter
Dietary supplements are not regulated as strictly as prescription medications. When manufacturing or labeling errors occur, consumers may unknowingly expose themselves to:
- Incorrect dosages
- Undeclared ingredients
- Potency inconsistencies
That’s why recall alerts like this are critical.
Even when no injuries are reported, correcting labeling or formulation issues helps prevent future harm.
If You Already Consumed the Product
If you have taken this supplement and feel fine, there is no need to panic.
However, you should:
- Stop using it
- Monitor your health
- Contact a provider if symptoms appear
If you are taking other medications or have underlying conditions, consult your healthcare provider for guidance.
Why This Recall Matters for Consumers
Dietary supplements and herbal products are widely used across the United States, but they are not regulated as strictly as prescription medications. The White Vein Tablets Recall 2026 is a reminder that consumers should carefully review supplement labels and purchase products from reputable manufacturers.
Excessive levels of active ingredients can increase the risk of side effects, especially for individuals with underlying health conditions or those taking other medications. Health experts recommend discussing supplement use with a healthcare professional before starting any new herbal or alkaloid product.
Staying informed about recalls like the White Vein Tablets Recall 2026 helps consumers make safer decisions and avoid potential health risks.
Official Recall Announcement
The recall was announced by the U.S. Food and Drug Administration and published on the FDA recall portal.
Consumers can read the official recall notice on the FDA recall website. fda.gov
Final Thoughts
When it comes to supplements, accurate labeling matters.
This recall serves as a reminder that even small dosage discrepancies can create unintended risks.
If you have this product, stop using it and request a refund.
You can review our latest consumer safety alerts and product recalls to stay informed about potential risks affecting households. https://everydayanswers.online/2026-product-recalls-and-safety-alerts/
Stay informed. Stay safe.
For more current safety alerts, visit our updated Product Recall Center here: https://everydayanswers.online/blog/
Frequently Asked Questions
Why were the White Vein chewable tablets recalled?
The tablets were recalled after testing found higher-than-declared levels of 7-hydroxymitragynine.
Which lot number is affected?
Lot number B# AAW.501.3 across multiple package sizes.
What should consumers do?
Consumers should stop using the product immediately and contact the company for a refund or replacement.